Videos / Recombinant respiratory syncytial virus pre-fusion F protein vaccine
In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).
Additional resources
Detection, Assessment and Management of Pulmonary Fibrosis
Practical Melanoma Management for GPs
Preventing Renal Failure in Type 2 Diabetes – New Options
Management of Post-Vaccination Reactions
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland